Ignite Creation Date:
2024-05-06 @ 4:26 PM
Last Modification Date:
2024-10-26 @ 2:10 PM
Study NCT ID:
NCT04988555
Status:
RECRUITING
Last Update Posted:
2024-01-18
First Post:
2021-07-26
Brief Title:
A Study of DSP-5336 in Relapsedrefractory AML ALL with or Without MLL Rearrangement or NPM1 Mutation
Sponsor:
Sumitomo Pharma America Inc
Organization:
Sumitomo Pharma America Inc
Organization Data
Organization:
Sumitomo Pharma America Inc
Class:
INDUSTRY
Study ID:
DSP-5336-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sumitomo Pharma America Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None